Aug 04, 2023 / 08:00AM GMT
Presentation
Aug 04, 2023 / 08:00AM GMT
=====================
Corporate Participants
=====================
* Christopher Cargill
Sosei Group Corporation - Representative Executive Officer, President, CEO & Director
* Hironoshin Nomura
Sosei Group Corporation - Executive Officer, Executive VP & CFO
* Matthew Barnes
Sosei Group Corporation - Head of Drug Disc., Exec. Off., Exec. VP, President of Heptares Therapeutics Ltd. and Head of UK R&D
* Satoshi Tanaka
Sosei Group Corporation - Executive Officer, Executive VP & President of Idorsia Pharmaceuticals Japan
=====================
Conference Call Participants
=====================
* Dion Stéfan Büchner
Pathology Associates Co., Ltd. - VP
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Hiroyuki Matsubara
Nomura Securities Co. Ltd., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Naoya
Nxera Pharma Co Ltd
(FRA:JSS)
€
5.1
-0.050 (-0.97%)
Market Cap: 477.99 Mil
Enterprise Value: 718.08 Mil
PE Ratio: 0
PB Ratio: 1.32
GF Score: 73/100 Q2 2023 Sosei Group Corp Earnings Presentation Transcript
Aug 04, 2023 / 08:00AM GMT
Release Date Price:
€11
(+0.92%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot